​
​

Pulse Biosciences Stock (NASDAQ:PLSE)

RevenueOwnershipFinancialsChartTranscripts
Pulse Biosciences by TradingView

Previous Close

$17.39

52W Range

$5.97 - $22.69

50D Avg

$17.36

200D Avg

$13.06

Market Cap

$1.05B

Avg Vol (3M)

$170.84K

Beta

1.75

Div Yield

-

PLSE Company Profile

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

56

IPO Date

May 18, 2016

Website

PLSE Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceSep 21
Cycle Units Products$84.00K
Systems Products$490.00K

Fiscal year ends in Dec 23 | Currency in USD

PLSE Financial Summary

Dec 23Dec 22Dec 21
Revenue-$700.00K$1.42M
Operating Income$-43.57M$-58.06M$-63.01M
Net Income$-42.21M$-58.95M$-63.16M
EBITDA$-43.57M$-58.06M$-63.01M
Basic EPS$-0.88$-1.74$-2.26
Diluted EPS$-0.88$-1.74$-2.26

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q3 24Oct 30, 24 | 9:42 PM
Q2 24Aug 12, 24 | 6:50 PM
Q1 24May 07, 24 | 12:00 AM

Peer Comparison

TickerCompany
ATRCAtriCure, Inc.
KRMDKORU Medical Systems, Inc.
AKYAAkoya Biosciences, Inc.
ATRIAtrion Corporation
OSUROraSure Technologies, Inc.
LMATLeMaitre Vascular, Inc.
HAEHaemonetics Corporation
ICUIICU Medical, Inc.
UTMDUtah Medical Products, Inc.
PDEXPro-Dex, Inc.
NYXHNyxoah S.A.